Saturday, July 11, 2026

Drug profile · INN

domperidone

domperidone (APO-DOMPERIDONE) is a dopamine d2 receptor antagonist. Associated with Apotex Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — domperidone

Quick answer

domperidone (APO-DOMPERIDONE) is a dopamine d2 receptor antagonist. Associated with Apotex Pty Ltd.

Key facts

INN domperidone
Brand APO-DOMPERIDONE
Mechanism Dopamine D2 receptor antagonist
Target D(2) dopamine receptor
Originator Apotex Pty Ltd

Mechanism of action

Dopamine D2 receptor antagonist

Primary target: D(2) dopamine receptor

Approval history

Authority Status Date
TGA approved

Related & competitor drugs

  1. aripiprazole Nervous system (N05)
  2. brexpiprazole Nervous system (N05)
  3. cabergoline Dopamine D2 receptor agonist
  4. clozapine Serotonin 2a (5-HT2a) receptor antagonist
  5. fluphenazine decanoate Dopamine D2 receptor antagonist
  6. fluphenazine hydrochloride Dopamine D2 receptor antagonist

Frequently asked questions

What is domperidone?

domperidone (APO-DOMPERIDONE) is a dopamine d2 receptor antagonist. Associated with Apotex Pty Ltd.

What is the brand name for domperidone?

APO-DOMPERIDONE is a marketed brand name for domperidone. Check FDA Drugs@FDA for the current US label holder and prescribing information.